These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
234 related articles for article (PubMed ID: 30513929)
21. Stereocontrolled total synthesis of tetrodotoxin from myo-inositol and D-glucose by three routes: aspects for constructing complex multi-functionalized cyclitols with branched-chain structures. Sato K; Akai S; Yoshimura J Nat Prod Commun; 2013 Jul; 8(7):987-98. PubMed ID: 23980434 [TBL] [Abstract][Full Text] [Related]
22. Both myo-inositol to chiro-inositol epimerase activities and chiro-inositol to myo-inositol ratios are decreased in tissues of GK type 2 diabetic rats compared to Wistar controls. Sun TH; Heimark DB; Nguygen T; Nadler JL; Larner J Biochem Biophys Res Commun; 2002 May; 293(3):1092-8. PubMed ID: 12051772 [TBL] [Abstract][Full Text] [Related]
23. Inositol as putative integrative treatment for PCOS. Genazzani AD Reprod Biomed Online; 2016 Dec; 33(6):770-780. PubMed ID: 27717596 [TBL] [Abstract][Full Text] [Related]
24. Ovulation induction with myo-inositol alone and in combination with clomiphene citrate in polycystic ovarian syndrome patients with insulin resistance. Kamenov Z; Kolarov G; Gateva A; Carlomagno G; Genazzani AD Gynecol Endocrinol; 2015 Feb; 31(2):131-5. PubMed ID: 25259724 [TBL] [Abstract][Full Text] [Related]
25. Updates on the myo-inositol plus D-chiro-inositol combined therapy in polycystic ovary syndrome. Unfer V; Porcaro G Expert Rev Clin Pharmacol; 2014 Sep; 7(5):623-31. PubMed ID: 24898153 [TBL] [Abstract][Full Text] [Related]
26. The combined therapy with myo-inositol and D-chiro-inositol reduces the risk of metabolic disease in PCOS overweight patients compared to myo-inositol supplementation alone. Nordio M; Proietti E Eur Rev Med Pharmacol Sci; 2012 May; 16(5):575-81. PubMed ID: 22774396 [TBL] [Abstract][Full Text] [Related]
27. Inositol's and other nutraceuticals' synergistic actions counteract insulin resistance in polycystic ovarian syndrome and metabolic syndrome: state-of-the-art and future perspectives. Paul C; Laganà AS; Maniglio P; Triolo O; Brady DM Gynecol Endocrinol; 2016 Jun; 32(6):431-8. PubMed ID: 26927948 [TBL] [Abstract][Full Text] [Related]
29. Effects of myo-inositol, gymnemic acid, and L-methylfolate in polycystic ovary syndrome patients. Stracquadanio M; Ciotta L; Palumbo MA Gynecol Endocrinol; 2018 Jun; 34(6):495-501. PubMed ID: 29265900 [TBL] [Abstract][Full Text] [Related]
30. [INVESTIGATIONS CONCERNING THE BIOSYNTHESIS OF CYCLITOLS, I. FORMATION OF D-PINITOL, D-INOSITOL AND SEQUOYITOL FROM MESO -INOSITOL IN LEAVES OF TRIFOLIUM INCARNATUM]. SCHOLDA R; BILLEK G; HOFFMANN-OSTENHOF O Hoppe Seylers Z Physiol Chem; 1964; 335():180-6. PubMed ID: 14124981 [No Abstract] [Full Text] [Related]
31. Biological Properties of Cyclitols and Their Derivatives. Şimşek Kuş N Chem Biodivers; 2024 Jan; 21(1):e202301064. PubMed ID: 37824100 [TBL] [Abstract][Full Text] [Related]
32. Ovulatory and metabolic effects of D-chiro-inositol in the polycystic ovary syndrome. Nestler JE; Jakubowicz DJ; Reamer P; Gunn RD; Allan G N Engl J Med; 1999 Apr; 340(17):1314-20. PubMed ID: 10219066 [TBL] [Abstract][Full Text] [Related]
33. Combining treatment with myo-inositol and D-chiro-inositol (40:1) is effective in restoring ovary function and metabolic balance in PCOS patients. Monastra G; Unfer V; Harrath AH; Bizzarri M Gynecol Endocrinol; 2017 Jan; 33(1):1-9. PubMed ID: 27898267 [TBL] [Abstract][Full Text] [Related]
34. Myo-inositol vs. D-chiro inositol in PCOS treatment. Formuso C; Stracquadanio M; Ciotta L Minerva Ginecol; 2015 Aug; 67(4):321-5. PubMed ID: 25670222 [TBL] [Abstract][Full Text] [Related]
35. Inositol: history of an effective therapy for Polycystic Ovary Syndrome. Bizzarri M; Carlomagno G Eur Rev Med Pharmacol Sci; 2014 Jul; 18(13):1896-903. PubMed ID: 25010620 [TBL] [Abstract][Full Text] [Related]
36. Purification and molecular structure of digalactosyl myo-inositol (DGMI), trigalactosyl myo-inositol (TGMI), and fagopyritol B3 from common buckwheat seeds by NMR. Gui W; Lemley BA; Keresztes I; Condo AM; Steadman KJ; Obendorf RL Carbohydr Res; 2013 Oct; 380():130-6. PubMed ID: 24036233 [TBL] [Abstract][Full Text] [Related]
37. Fluorinated cyclitols as useful biological probes of phosphatidylinositol metabolism. Schedler DJ; Baker DC Carbohydr Res; 2004 Jun; 339(9):1585-95. PubMed ID: 15183732 [TBL] [Abstract][Full Text] [Related]
38. Abnormalities in myo-inositol metabolism associated with type 2 diabetes in mice fed a high-fat diet: benefits of a dietary myo-inositol supplementation. Croze ML; Géloën A; Soulage CO Br J Nutr; 2015 Jun; 113(12):1862-75. PubMed ID: 25990651 [TBL] [Abstract][Full Text] [Related]